|
OMIM |
Link |
Information gain |
01 |
|
OPTB3
|
[NCBI]
|
0.00173067
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
0.00160992
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
0.00127609
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.00092257
|
|
|
SLC4A1
|
[NCBI]
|
0.000874593
|
|
|
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation
|
[NCBI]
|
0.000774688
|
|
|
renal tubular acidosis, distal, with hemolytic anemia
|
[NCBI]
|
0.000552505
|
|
|
RTADR
|
[NCBI]
|
0.000552505
|
|
|
SRS
|
[NCBI]
|
0.000460245
|
|
|
CA2
|
[NCBI]
|
0.00040148
|
|
|
renal tubular acidosis, proximal
|
[NCBI]
|
0.000331004
|
|
|
OCRL
|
[NCBI]
|
0.000242559
|
|
|
ATP6V0A4
|
[NCBI]
|
0.00023749
|
|
|
renal tubular acidosis iii
|
[NCBI]
|
0.000220505
|
|
|
SLC4A4
|
[NCBI]
|
0.000215133
|
|
|
HOMG3
|
[NCBI]
|
0.00021328
|
|
|
PHA2
|
[NCBI]
|
0.000194257
|
|
|
RA
|
[NCBI]
|
0.000173485
|
|
|
carnitine palmitoyltransferase i deficiency
|
[NCBI]
|
0.000147685
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
0.000133277
|
|
|
ATP6V1B1
|
[NCBI]
|
0.000130575
|
|
|
CA1
|
[NCBI]
|
0.000130575
|
|
|
thyrotoxic periodic paralysis
|
[NCBI]
|
0.000127644
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
0.000110727
|
|
|
hyperparathyroidism, neonatal self-limited primary, with hypercalciuria
|
[NCBI]
|
0.00011017
|
|
|
hypomagnesemia, renal, with ocular involvement
|
[NCBI]
|
7.92517e-05
|
|
|
KCNK5
|
[NCBI]
|
7.89672e-05
|
|
|
ATP6V0E2
|
[NCBI]
|
7.89672e-05
|
|
|
SLC12A7
|
[NCBI]
|
7.89672e-05
|
|
|
say syndrome
|
[NCBI]
|
7.37614e-05
|
|
|
hawkinsinuria
|
[NCBI]
|
6.96835e-05
|
|
|
arthrogryposis, renal dysfunction, and cholestasis
|
[NCBI]
|
6.14354e-05
|
|
|
VPS33B
|
[NCBI]
|
5.66176e-05
|
|
|
FOXI1
|
[NCBI]
|
5.66176e-05
|
|
|
TINU
|
[NCBI]
|
5.60292e-05
|
|
|
HHRH
|
[NCBI]
|
5.60292e-05
|
|
|
3-@methylglutaconic aciduria, type i
|
[NCBI]
|
5.32371e-05
|
|
|
AUH
|
[NCBI]
|
5.04502e-05
|
|
|
xanthinuria, type i
|
[NCBI]
|
4.98027e-05
|
|
|
dent disease 1
|
[NCBI]
|
4.98027e-05
|
|
|
CLDN16
|
[NCBI]
|
4.90287e-05
|
|
|
TCIRG1
|
[NCBI]
|
4.56908e-05
|
|
|
OPTB1
|
[NCBI]
|
4.07231e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
3.71729e-05
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
3.71729e-05
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
3.67278e-05
|
|
|
FIH
|
[NCBI]
|
3.62955e-05
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
3.45327e-05
|
|
|
UGB
|
[NCBI]
|
3.1673e-05
|
|
|
B2M
|
[NCBI]
|
2.91191e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
2.87802e-05
|
|
|
wilson disease
|
[NCBI]
|
1.96747e-05
|
|
|
SLE
|
[NCBI]
|
1.38802e-05
|
|
|
PTH
|
[NCBI]
|
7.31143e-06
|
|
|
NPPA
|
[NCBI]
|
4.7623e-06
|
|
|
PRL
|
[NCBI]
|
4.25045e-06
|
|
|
AVP
|
[NCBI]
|
9.48422e-07
|
|
|
EPO
|
[NCBI]
|
2.10149e-07
|
|